No abstract

Epistaxis is the most frequent, but readily treatable rhinological emergency. However, epistaxis can be difficult to control and can require hospitalization. First line treatments sometimes fail and episodes of epistaxis recur. The present study assesses factors involved in being hospitalized for epistaxis or re bleeding after treatment.This retrospective study enrolled 923 patients male, n 628 57.3% ; female, n 468 42.7% ; mean age, 58.3 range, 1 98 years who were treated for 1,096 episodes of epistaxis at Okayama Saiseikai General Hospital between January 2006 and December 2013. Among the 1,096 episodes, 66 6.0% required hospitalization and 135 12.3% recurred. Patients with bleeding points other than the nasal septum, who were treated with gauze packing, who had a history of hypertension or other heart diseases, who were receiving anticoagulant therapy and who were treated by a family doctor before the initial visit, tended to require treatment with hospitalization. Bleeding points other than the nasal septum, a medical history of hypertension, and treatment with gauze packing were significant risk factors for re bleeding. In conclusion, these factors should be considered before treating and admitting epistaxis patients to hospital.

The median duration of S-1 administration as adjuvant chemotherapy for SCCHN was 7 months (range = 0.1-58 months). Disease-free survivals (DFSs) were generally longer when S-1 administration periods were longer. After adjusting for prognostic factors, S-1 administration periods of 24 months or longer showed significantly lower hazard ratios (HRs) than 0-12 months.

Acute vertigo and dizziness are two of the most common symptoms that prompt patient visits to internal medicine practitioners and the emergency room. Most of these patients are diagnosed as having peripheral vertigo. However, central vertigo is identified in some cases that is sometimes life threatening and the diagnoses require careful attention. Although vertigo due to cerebrovascular disorders is usually associated with other neurologic symptoms or signs, small infarcts in the cerebellum or brainstem can present with vertigo without other localizing symptoms. Diagnosis of such isolated vertigo has been increasing with recent developments in clinical neuro-otology and neuroimaging. We recently encountered five patients with central vertigo who were referred to the otolaryngology department as having peripheral vertigo from an internal medicine department and an emergency room. We present on and discuss the clinical manifestations of nystagmus, localization of the lesion based on magnetic resonance imaging (MRI) findings of the brain, and risk factors (hypertension and diabetes, obesity, heart disorder) of these cases. isolated vertigoCase reports of isolated vertigo due to cerebrovascular problems, in reference to differential diagnosis with peripheral vertigo.

No abstract